套现上瘾？易瑞生物控股股东再抛减持计划

Core Viewpoint - The major shareholders of Easyway Bio (300942) plan to reduce their holdings in the company by up to 3% of the total share capital within three months, starting from the announcement date, due to personal funding needs [1][2]. Shareholder Reduction Plans - The controlling shareholder, Easyway (Hainan) Venture Capital Co., Ltd., intends to reduce its holdings by up to 11,521,758 shares, representing 2.84% of the total share capital [1]. - Easyway's other shareholders, Easy Dary and Easy Kairui, plan to reduce their holdings by up to 288,500 shares (0.07%) and 341,800 shares (0.08%), respectively [1]. - The total reduction across all shareholders will not exceed 3% of the company's total share capital [2]. Previous Share Reduction - Last month, the controlling shareholder completed a reduction of 4,167,000 shares, accounting for 1.03% of the total share capital, between September 2 and September 5, 2025 [2]. - Following the previous reduction, the total shares held by the controlling shareholder decreased from 23,829,340 shares to 23,412,640 shares, reducing their ownership percentage from 58.83% to 57.80% [2]. Company Financial Performance - In the first half of 2025, the company reported revenue of 109 million yuan, a year-on-year increase of 5.4% [3]. - The net profit attributable to shareholders was 2.34 million yuan, a recovery from a loss of 1.56 million yuan in the same period last year [3]. - The company's stock price decreased by 3.40% to 10.50 yuan per share as of October 10, with a market capitalization of 4.253 billion yuan, although the stock has risen by 22.75% year-to-date [3].